about
Lung cancer chemoprevention: current status and future prospectsTwenty five year mortality and air pollution: results from the French PAARC surveyEffect of active smoking on the human bronchial epithelium transcriptome.Biological activity of celecoxib in the bronchial epithelium of current and former smokers.Sex-specific expression of gastrin-releasing peptide receptor: relationship to smoking history and risk of lung cancer.Detection of early lung cancer.Inhibition of lung carcinogenesis and critical cancer-related signaling pathways by N-acetyl-S-(N-2-phenethylthiocarbamoyl)-l-cysteine, indole-3-carbinol and myo-inositol, alone and in combination.Vascular endothelial growth factor receptor 2-targeted chemoprevention of murine lung tumors.Early detection for lung cancer. New tools for casefindingImpact of smoking cessation on global gene expression in the bronchial epithelium of chronic smokers.Genetic instability in epithelial tissues at risk for cancer.High prevalence of lung cancer in a surgical cohort of lung cancer patients a decade after smoking cessationChemoprevention of murine lung cancer by gefitinib in combination with prostacyclin synthase overexpression.A randomized phase II chemoprevention trial of 13-CIS retinoic acid with or without alpha tocopherol or observation in subjects at high risk for lung cancer.Screening for lung cancer: in pursuit of pre-metastatic disease.Lung cancer chemoprevention with celecoxib in former smokers.Progress in lung cancer chemoprevention.Lung cancer screening guidelines: common ground and differences.Dietary agents for prevention and treatment of lung cancer.Oral iloprost improves endobronchial dysplasia in former smokers.Translating cancer 'omics' to improved outcomes.Curcumin: a novel Stat3 pathway inhibitor for chemoprevention of lung cancerGene-promoter hypermethylation as a biomarker in lung cancer.Chemoprevention of lung cancer: concepts and strategies.Proliferative changes in the bronchial epithelium of former smokers treated with retinoids.Pathogenesis of lung cancer: 100 year report.Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer ConsortiumChaperonin (HSP60) and annexin-2 are candidate biomarkers for non-small cell lung carcinoma.Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosisEarly detection and chemoprevention of lung cancer.Resveratrol inhibits benzo[a]pyrene-DNA adduct formation in human bronchial epithelial cellsEffect of dietary green tea extract and aerosolized difluoromethylornithine during lung tumor progression in A/J strain miceChemoprevention of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelinesPatient Perspectives on Low-Dose Computed Tomography for Lung Cancer Screening, New Mexico, 2014.Physical activity, white blood cell count, and lung cancer risk in a prospective cohort study.A Randomized Phase IIb Trial of myo-Inositol in Smokers with Bronchial Dysplasia.Molecular damage in the bronchial epithelium of current and former smokers.Self-reported prior lung diseases as risk factors for non-small cell lung cancer in Mexican Americans.Lung cancer stem cells: Molecular features and therapeutic targets.Lung cancer screening: review and performance comparison under different risk scenarios.
P2860
Q26995495-753BC1C0-D677-4ED1-9B42-1861EEA89185Q28764258-51CB1FE6-415D-432D-AB85-5C3C3E70D7FFQ33295454-7D490979-2D23-49E1-8D22-2809B338E3E4Q33640402-BBD3E139-2260-4FBD-B344-34D08F6E73AEQ33885599-42E5AE7D-A8D4-4AF1-BA4A-03B32110D218Q34004455-6C0C1B42-5043-45AB-825C-6E017C0480A2Q34094986-DAD3E757-33CB-4F72-9ECE-652C8182099CQ34103766-1EAE024D-E681-44C8-8337-7312DD3FEBE6Q34203799-4691C1B1-35BE-4DDF-9691-B3A225615872Q34273137-734BE771-0316-4D81-8B94-F826A711DE69Q34497351-ECD94B54-C371-4964-9EF6-2B4E964CECC0Q34668063-198AF711-5AB9-4B9F-A062-CC18FCFDB9F2Q34994448-5173DBEB-432A-4ED1-A10A-2513153E25A2Q35010602-4E6E5F93-5A65-496D-894E-49535B074655Q35037686-6BD0713B-C09E-41CE-8069-E2F94687FBF7Q35156358-D933FB5C-612C-462A-920C-E7D46D875408Q35198453-71B7F9AE-9EE9-4557-B0EE-FBF466D1C644Q35200558-CCFC30FA-1C2D-473C-8B02-1497CBDDAC28Q35535937-629827D3-9D83-4F6B-8E30-131EA2BE9A70Q35652044-65B3C57F-7703-4749-8E02-01FD58BBF7D5Q35694365-5F3C709B-2A00-411A-BCE7-BB7B4233D358Q35870692-C55F30A4-8A05-42FA-8698-EC2CC7B71FCBQ35877182-8A54B953-EE00-43D1-9FE9-B78D92ED05D1Q36185641-5117E8AB-4B5F-497D-94D4-FFFE11AD86ECQ36231743-D5F5FDA8-DC23-4DD2-9015-22FEAB1B007AQ36233709-C92C0668-794B-4E04-AA7B-0654348F7190Q36243132-FBB8F202-A0A6-4176-9CCF-0793E5DE8CD5Q36273955-24CDD4D8-1874-4534-82F8-125DDE2E9FB1Q36324689-44DA1DA1-2CC7-4955-94EA-D42E39CC9DD8Q36505771-8F53817F-895F-4E87-9E94-7467D083BF06Q36695365-C4A73EF1-075A-41EE-A886-3CFF669FB7B2Q36837995-6990C426-6794-4779-8004-CA2E3CC30E58Q37111529-C12A0DB5-0C0A-4767-BF71-2A775F53A1ACQ37193850-03BFE6DE-AED3-4274-9708-336ABF2D31FAQ37217621-65297578-BDF3-4B7D-8CE1-D6842D6B81C6Q37470702-65782684-8BBD-47B0-8080-F3CB1ED47BC3Q37541079-0A4AFA00-D35D-493C-AF64-19C3FA7738A4Q37574026-0331A556-4FB2-4DFD-BC24-D8F122294921Q37629583-DC006216-CFD0-4D3F-832E-173FC819C038Q38155065-3BBBFFB5-2333-4C1A-868D-3EDE9F6EF59E
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Lung carcinoma in former smokers.
@en
Lung carcinoma in former smokers.
@nl
type
label
Lung carcinoma in former smokers.
@en
Lung carcinoma in former smokers.
@nl
prefLabel
Lung carcinoma in former smokers.
@en
Lung carcinoma in former smokers.
@nl
P2093
P2860
P1433
P1476
Lung carcinoma in former smokers.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1097-0142(19960901)78:5<1004::AID-CNCR10>3.0.CO;2-6
P407
P577
1996-09-01T00:00:00Z